Curie Oncology And Oncoshot Use AI To Improve Patient Outcomes In Asia

By PR Newswire
Publication Date: 2025-12-15 11:26:00

SINGAPORE, December 15, 2025 /PRNewswire/ — Curie Oncology, one of Southeast Asia’s fastest-growing private oncology networks, has partnered with Singapore-based health technology company Oncoshot to deploy AI-powered clinical research tools that provide patients with faster access to clinical trials.

From left to right: Ruslan Enikeev, CTO and co-founder of Oncoshot; Adrian Chan, integration project manager at Oncoshot; Chua Chee Yong, CCO of Oncoshot; Dr. Toh Chee Keong, medical oncologist at Curie Oncology; and Jing Yee Ooi, study research coordinator at Curie Oncology.

The partnership represents one of the first real-world implementations of oncology-focused AI within a regional private cancer group and complements previous deployments across Singapore’s public healthcare system.

Curie Oncology: Using AI to make more studies accessible to patients

Curie Oncology is currently conducting numerous clinical trials in Singapore and Malaysia. As the group expands its research footprint, the volume of…

Related Posts